Imaging | Clinical Research

CREATING THE RIGHT SPIRIT

TissueGnostics is an innovative enterprise on the cutting edge of science and technology our activities are guided by economic principles. We provide our customers with a new generation of imaging and analysis tools for basic and clinical research.

We offer objectivity, quality and innovation and continuously demand it from ourselves. Through const professional development, We maintain top-level scientific standards and competence by constantly reviewing and improving our processes, both scientific and business.

Hallmarks of our work include creativity, commitment and mutual understanding at all levels of operation. We make sure that our staff members enjoy a pleasant working environment that brings out their best performance.

EXCHANGING THOUGHTS

Everyday communication is about people exchanging ideas. We promote sincere communication in an atmosphere of trust and mutual respect to further creativity, satisfaction and social competence.

We are closely cooperating with clinicians and research facilities to ensure that our development work will always be customer-oriented. Custom requests and needs expressed by individuals are being incorporated to gear our products for a broad spectrum of challenges.

JOINING FORCES

We are making every effort to promote a sense of community enabling us to act as a team.

Our daily interactions are guided by mutual respect and pervaded by a peer-to-peer spirit. We strongly believe that social competence should not be a hollow phrase. Therefore we practice what we preach.

Our efforts are supported by solid training, continuous professional development, setting targets, and being responsible individuals. We cannot accept poor working conditions.

2021 REDI Industry Fellowship Program in collaboration with Queensland University of Technology
Development of a novel in situ tool for prostate cancer precision diagnostics (2022 - 2023)
2021 COMET K1 Competence Centres for Excellent Technologies
Program microONE – Microplastic Particles: a Hazard for Human Health? (2022 – 2025)
2020 K1 Center
S3AI - Security and Safety for Shared AI by Deep Model Design (2020 – 2023)
2019 Bridge Project, FFG
Deep nuclei analysis: Deep learning for improved nuclei segmentation and knowledge transfer methods in microscopic images (FFG Project No. 872636; 2019-2022)
2018 Marie Skłodowska‐Curie European Training Network (Horizon 2020)
Helical: establishment of a European training network to prepare the next generation of Health Informatics Researchers (Grant Agreement 813545; 2019-2022)
2016 1st Place in the category „Image Analysis“
in the 3rd International Scanner Contest during the 13th European Congress on Digital Pathology at the Charité Berlin, Germany
2015 Marie Skłodowska‐Curie European Training Network (Horizon 2020)
Calcium Sensing Receptor (CaSR): Biomedicine; (Grant Agreement 675228; 2016-2020)
2014 Marie Skłodowska‐Curie European Training Network (FP7)
European Network on Cell Migration Studies (InCeM, Grant Agreement 642866; 2015-2019)
2014 Marie Skłodowska‐Curie European Training Network (FP7)
ALK Activation as a target of TRAnslational Science: Break free from Cancer (ALKATRAS, Grant Agreement 675712; 2015-2019)
2013 ZIT Innovation
„Entwicklung eines Systems zur Isolation von einzelnen Prostatakarzinomstammzellen“ (2013-2015)
2012 Marie Skłodowska‐Curie European Training Network (FP7)
Academia and Industry Collaboration for Digital Pathology (AIDPATH, Grant Agreement 612471; 2013-2017)
2011 ZIT Call-Innovation
Entwicklung und Validierung eines Analyseautomaten für Körperflüssigkeiten und peripheres Blut
2011 Science2Bussines Award
Kooperationspartner: Med. Uni. Wien, Univ. Prof. DI. Dr. Isabella Ellinger
2009 ZIT Call
Patient im Fokus (2.Preis) Methode zur validierten, quantitativen Analyse von Biomarkern beim Mammakarzinom
2009 Oncotyrol, Centre for personalized medicine
Prostate Biobank - new marker selection for treatment
2008 Bridge Project, FFG
Automatisierte Zellerkennungstechnologie fuer Forschung und Diagnose
2007 EU-Projekt
Cryobanking of stem cells for human therapeutic applications
2006 GENAU-Projekt mit der Uni Innsbruck, Urologie
ProCAP Prostate Cancer Proteomics
2004 WWTF Life Science Call Start-up
Preis Entwicklung eines Gewebecytometers für die klinische Diagnostik

HISTORY

TissueGnostics was established in 2003 in Austria after nearly a decade of basic research. The goal was to supply scientists with qualitative and observer independent results for cell and tissue analysis in tissue context and this in automated format and significantly less time. Katja Österreicher, Georg Steiner and Dr. Rupert Ecker, the three co-founders of the company, with the aid of a dozen of development partners (Medical University Vienna, Memorial Sloan-Kettering Cancer Center New York, Ludwig Boltzmann Institute for Cancer Research, Vienna; Fred Hutchinson Cancer Center, Seattle; Brighamand Women`s Hospital, Boston; etc.) succeeded in reaching this target by 2005.

The product launch of TissueFAXS 1.0 was in 2006 and provided tissue imaging and automated identification and functional characterization of single cells in tissue sections. In contrast to morphometry, which provides values referring to the metric dimensions of cells, the term “tissue cytometry” refers to quantification of molecular parameters. Though methodically different, tissue cytometry exhibits a functional similarity to flow cytometry. While flow cytometer is restricted to cells in suspension (e.g. blood) and cannot be applied to solid tissue, tissue cytometry refers to the cytometric analysis (as opposed to morphometric analysis) of histological sections. TissueGnostics has been the first manufacturer of tissue cytometers offering a flow cytometry-like workflow (but applied to tissue sections).

Today in 2022 TissueGnostics is a successfull company with subsidiaries in the EU, the USA and China and with customers on all continents.